NCT07177898View on ClinicalTrials.gov

ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICS

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 14, 2023

Primary Completion Date

September 23, 2024

Study Completion Date

November 18, 2024

Conditions
Diabetic Kidney Disease (DKD)
Interventions
DRUG

Allopurinol

Group A received allopurinol with lisinopril, and Group B received lisinopril alone

Trial Locations (1)

54000

King Edward Medical University, Lahore

Sponsors
All Listed Sponsors
collaborator

King Edward Medical University

OTHER

lead

Narowal Medical College

OTHER_GOV

NCT07177898 - ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICS | Biotech Hunter | Biotech Hunter